|
⚲
|
| Keyboard |
| POPS Richard F
✚
|
|
|---|---|
| CIK # | 0001126490 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001126490] | |
| 4 | [0001126490] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| POPS Richard F | |
| Neurocrine Biosciences Inc | |
| Alkermes PLC | |
| Epizyme Inc | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alkermes PLC ALKS
Restricted Stock Unit Award · derivative
|
2026-03-02 | Grant | 88,843 | $0.00 | |
|
Alkermes PLC ALKS
Ordinary Shares
|
2026-02-05 | Tax withheld | 62,230 | $33.55 | 2,087,816 |
|
Alkermes PLC ALKS
Ordinary Shares
|
2026-02-05 | Grant | 149,580 | ||
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-22 | Option exercise | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-21 | Grant | 3,318 | $0.00 | |
|
Alkermes PLC ALKS
Employee Stock Option (Right to Buy) · derivative
|
2025-02-19 | Grant | 293,921 | $0.00 | |
|
Alkermes PLC ALKS
Ordinary Shares
|
2025-02-06 | Grant | 190,640 | ||
|
Alkermes PLC ALKS
Ordinary Shares
|
2025-02-06 | Tax withheld | 79,925 | $31.39 | 2,508,846 |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-22 | Grant | 2,869 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-05-17 | Option exercise | 4,199 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2024-05-17 | Option exercise | 4,199 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-05-17 | Sell | 2,100 | $141.84 | 297,864 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-13 | Sell | 23,200 | $140.33 | 3,255,656 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-03-13 | Option exercise | 23,200 | $42.76 | 992,032 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-13 | Option exercise | 23,200 | $42.76 | 992,032 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-03-11 | Option exercise | 100 | $42.76 | 4,276 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-11 | Sell | 100 | $140.00 | 14,000 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-11 | Option exercise | 100 | $42.76 | 4,276 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-03-08 | Sell | 1,700 | $140.05 | 238,085 |
| showing 20 of 200 most recent transactions | |||||